Cryolife, Inc.
NYSE:CRY 2:08:56 PM EDT
| Market Cap (Intraday) | 1.15B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 419.86 |
| 10-Day MA | $29.29 |
| 50-Day MA | $27.99 |
| 200-Day MA | $23.37 |
Cryolife, Inc. Stock, NYSE:CRY
1655 Roberts Boulevard NW, Kennesaw, Georgia 30144-3632
United States of America
Phone: +1.770.419.3355
Number of Employees: 1200
Description
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.